clinical trial · NCT00840866
Cefprozil 500 mg Tablets Under Fed Conditions
Teva Pharmaceuticals USA·phase1·completed·n = 39
HealthycefprozilCefzil®
brief summary
The objective of this study is to compare the relative bioavailability of cefprozil 500 mg tablets with that of Cefzil 500 mg tablets in healthy, non-smoking adults under non-fasting conditions.
started
Sep 1, 2003
primary completion
Sep 1, 2003
completion
Sep 1, 2003
last updated
Aug 20, 2024
detailed description
Criteria for Evaluation: FDA Bioequivalence Criteria
Statistical Methods: FDA bioequivalence statistical methods
official title
A Relative Bioavailability Study of Cefprozil 500 mg Tablets Under Non-Fasting Conditions
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol